Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Mabwell (Shanghai) Bioscience Co. Ltd. A
688062Current price
23.8 CNY
-0.6 CNY (-2.46%)
Last closed
24.55 CNY
Company
www.mabwell.com
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
Shanghai Stock Exchange
Capitalization
9 197 653 207 CNY
Yield for 12 month
-10.19 %
1Y
3Y
5Y
10Y
15Y
688062
Mabwell (Shanghai) Bioscience Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of biological products in China and internationally. The company offers its products for auto-immune, oncology, ophthalmologic, and infectious diseases, as well as metabolic disorders, etc. It offers JUNMAIKANG, an autoimmune Adalimumab injection. The company's oncology products pipeline includes 9MW2821 and 6MW3211, which are in phase II of clinical trial; 9MW2921, 9MW3811, and 7MW3711, which are in phase I clinical trials; 9MW0321; and 8MW0511, which is in phase III clinical trial. It also develops autoimmune products, such as 9MW1911 and 9MW3811, which are in phase 1 clinical trial; metabolic products comprising MAILISHU and 9MW3011; ophthalmology candidates, including 9MW0813 and 9MW0211 that are in phase III clinical trial; and 9MW1411, an infectious product candidate. The company was founded in 2017 and is based in Shanghai, China. Address: Building 2, Shanghai, China, 201210
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
253.14 CNYP/E ratio
–Dividend Yield
–Current Year
+128 209 573 CNY
Last Year
+27 809 310 CNY
Current Quarter
+48 113 288 CNY
Last Quarter
+67 752 802 CNY
Current Year
+126 835 723 CNY
Last Year
+27 738 460 CNY
Current Quarter
+42 810 151 CNY
Last Quarter
+66 865 750 CNY
Key Figures 688062
1 year
3 years
5 years
10 years
EBITDA
-1 000 665 889 CNY
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-14.69 %
PEG Ratio
–
Return On Equity TTM
-44.75 %
Wall Street Target Price
253.14 CNY
Revenue TTM
169 915 790 CNY
Book Value
4.87 CNY
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
167.7 %
Dividend Yield
–
Gross Profit TTM
25 863 774 CNY
Earnings per share
-2.71 CNY
Diluted Eps TTM
-2.71 CNY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 688062
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 688062
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 688062
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
57.6534
Price Sales TTM
54.1307
Enterprise Value EBITDA
-5.62
Price Book MRQ
4.7831
Financials 688062
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 688062
For 52 weeks
19.96 CNY
37.11 CNY
50 Day MA
23.31 CNY
Shares Short Prior Month
–
200 Day MA
28.4 CNY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart